Published works

Chronic Kidney Disease (CKD)

226 Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study. J Clin Med. 2024
doi: 10.3390/jcm13030736. PubMed
224 Comparison of Urinary Liver Fatty Acid Binding Protein Level and Pathologic Biopsy Findings 1 Year After Kidney Transplantation. Transplant Proc. 2024
doi: 10.1016/j.transproceed.2023.12.016. PubMed
218 Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease. J Pers Med. 2023
doi: 10.3390/jpm13101481. PubMed
214 Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes. Biomedicines. 2023
doi: 10.3390/biomedicines11113020. PubMed
211 Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations. Sci Rep. 2023
doi: 10.1038/s41598-023-38507-w PubMed

227 Urinary liver-type fatty acid-binding protein levels may be associated with the occurrence of acute kidney injury induced by trauma. Front Med (Lausanne). 2024
doi: 10.3389/fmed.2024.1346183. PubMed
225 Urine oxygenation predicts COVID 19 risk. Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5. PubMed
223 Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKI. Nephrology (Carlton). 2024
doi: 10.1111/nep.14271. PubMed
222 How to Construct an Optimal Risk Model for Contrast-induced Nephropathy. Intern Med. 2024
doi: 10.2169/internalmedicine.3209-23. PubMed
221 The Experience of Using Urinary Liver-Type Fatty Acid-Binding Protein for Follow-Up of Toluene Poisoning: A Case Report. Cureus. 2023
doi: 10.7759/cureus.50438. PubMed

201 Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
doi: 10.5455/OVJ.2022.v12.i6.12 PubMed
188 Urinary L-type fatty acid-binding protein isa predictor of cisplatin-induced acute kidney injury. BMC Nephrol. 2022
doi: 10.1186/s12882-022-02760-4. PubMed
184 Clinical Utility of a Biomarker to DetectContrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures. Cardiorenal Med. 2022
doi: 10.1159/000520820. PubMed
167 Changing trends in lipid profile and biomarkers of renalfunction and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofoviralafenamide: a prospective observational study. AIDS Res Ther.2021
doi: 10.1186/s12981-021-00354-y. PubMed

217 Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury. Nephrology (Carlton). 2023
doi: 10.1111/nep.14254. PubMed
206 Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments. J Am Heart Assoc.2023
doi: 10.1161/JAHA.122.028146. PubMed
205 Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients. Int Urol Nephrol.2023
doi: 10.1007/s11255-023-03532-1. PubMed
182 Tubular Injury Causing Protracted GlycosuriaFollowing Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in theDevelopment of Protracted Hypoglycemia and Ketoacidosis. Tohoku J ExpMed.2021
doi: 10.1620/tjem.255.291. PubMed
179 Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition onBiomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized ControlledTrial. J Diabetes Res.2021
doi: 10.1155/2021/7382620. PubMed

197 The moderate-intensity continuous exercisemaintains renal blood flow and does not impair the renal function . Physiol Rep. 2022
doi: 10.14814/phy2.15420. PubMed
194 Xanthine Oxidoreductase Activity in MarathonRunners: Potential Implications for Marathon-Induced Acute Kidney Injury. J Appl Physiol. 2022
doi: 10.1152/japplphysiol.00669.2021. PubMed
181 Wearing a face mask duringcontrolled-intensity exercise is not a risk factor for exertional heatstroke: A pilot study. Acute Med Surg.2021
doi: 10.1002/ams2.712. PubMed
178 Exercise Ameliorates Diabetic Kidney Diseasein Type 2 Diabetic Fatty Rats. Antioxidants (Basel).2021
doi:10.3390/antiox10111754. PubMed

225 Urine oxygenation predicts COVID 19 risk. Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5. PubMed
201 Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
doi: 10.5455/OVJ.2022.v12.i6.12 PubMed
217 Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury. Nephrology (Carlton). 2023
doi: 10.1111/nep.14254. PubMed
209 Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone. Nephrology (Carlton).2023
DOI: 10.1111/nep.14162 PubMed
208 Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases. Care Explor. 2023
doi: 10.1097/CCE.0000000000000873. PubMed